Split History
ETFs Holding MDVN »    MDVN Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Medivation is a biopharmaceutical company focused on the development and commercialization of therapies to treat diseases. Co.'s principal program is XTANDI® (enzalutamide) capsules, which is partnered with Astellas Pharma Inc. (Astellas). The program had received marketing approval in the U.S., Europe, and various other countries worldwide for the treatment of patients with metastatic castration-resistant prostate cancer and in Japan for the treatment of patients with castration-resistant prostate cancer. Together with Astellas, Co. is also conducting investigational studies of enzalutamide in prostate cancer and in advanced breast cancer. According to our MDVN split history records, Medivation has had 2 splits.
MDVN split history picture
Medivation (MDVN) has 2 splits in our MDVN split history database. The first split for MDVN took place on September 24, 2012. This was a 2 for 1 split, meaning for each share of MDVN owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. MDVN's second split took place on September 16, 2015. This was a 2 for 1 split, meaning for each share of MDVN owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Medivation splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the MDVN split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Medivation shares, starting with a $10,000 purchase of MDVN, presented on a split-history-adjusted basis factoring in the complete MDVN split history. MDVN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/26/2006
End date: 05/25/2016
Start price/share: $1.11
End price/share: $61.48
Dividends collected/share: $0.00
Total return: 5,438.74%
Average Annual Total Return: 49.36%
Starting investment: $10,000.00
Ending investment: $553,729.62
Years: 10.01
Date Ratio
09/24/20122 for 1
09/16/20152 for 1
MDVN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MDXG Split History
MEIP Split History
MELA Split History
MMM Split History
MMSI Split History
MOH Split History
MRK Split History
MSON Split History
MYGN Split History
MYL Split History

SS&C Technologies Holdings, Inc. (SSNC)
China Recycling Energy Corporation. (CREG)
Pacific Drilling S.A. (PACD)
Net Element, Inc. (NETE)
Ebix, Inc. (EBIX)
Onconova Therapeutics, Inc. (ONTX)
Axcelis Technologies, Inc. (ACLS)
PetroQuest Energy, Inc. (PQ)
Cinedigm Corp. (CIDM)
StemCells, Inc. (STEM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

MDVN Insider Buying

MDVN Split History | www.SplitHistory.com | Copyright © 2013 - 2016, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.